ViiV Healthcare

GSK posts data on HIV assets vying for roles in 6-month combo

GSK shared clinical data on three potential long-acting HIV therapies, providing a look at how its plans to create a six-month regimen are shaping up.

Nick Paul Taylor Mar 12, 2025 11:25am

Electromicrograph showing an HIV-infected T cell in blue and yellow

HIV protein inhibited by Rukobia linked to cardio comorbidities

Nov 30, 2023 9:30am

GSK drops one of 2 maturation inhibitors in HIV pipeline

Apr 26, 2023 8:12am

GSK gives early look at HIV bNAb's power

Oct 25, 2022 10:00am

ViiV research strategy chief's long quest to 'cure' HIV

Jun 30, 2022 11:30am